Correlation Between Kezar Life and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Structure Therapeutics American, you can compare the effects of market volatilities on Kezar Life and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Structure Therapeutics.
Diversification Opportunities for Kezar Life and Structure Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Kezar and Structure is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Kezar Life i.e., Kezar Life and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Kezar Life and Structure Therapeutics
Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Structure Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 1.32 times less risky than Structure Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Structure Therapeutics American is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 2,819 in Structure Therapeutics American on November 2, 2024 and sell it today you would earn a total of 213.00 from holding Structure Therapeutics American or generate 7.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kezar Life Sciences vs. Structure Therapeutics America
Performance |
| Timeline |
| Kezar Life Sciences |
| Structure Therapeutics |
Kezar Life and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kezar Life and Structure Therapeutics
The main advantage of trading using opposite Kezar Life and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Kezar Life vs. Century Therapeutics | Kezar Life vs. Mineralys Therapeutics, Common | Kezar Life vs. Nkarta Inc | Kezar Life vs. Surrozen |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |